ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 143 filers reported holding ANI PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $371,584 | +57.0% | 6,400 | +45.6% | 0.02% | +53.8% |
| Q2 2023 | $236,691 | -75.5% | 4,397 | -85.3% | 0.01% | -80.3% |
| Q2 2020 | $967,000 | -31.9% | 29,902 | -14.2% | 0.07% | -37.1% |
| Q1 2020 | $1,421,000 | -39.2% | 34,871 | -8.1% | 0.10% | -9.5% |
| Q4 2019 | $2,339,000 | -17.8% | 37,931 | -2.9% | 0.12% | -18.9% |
| Q3 2019 | $2,846,000 | +17.8% | 39,045 | +32.8% | 0.14% | +20.2% |
| Q2 2019 | $2,416,000 | – | 29,397 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 326,778 | $20,152,000 | 2.95% |
| Hawk Ridge Capital Management | 188,761 | $11,641,000 | 1.89% |
| Global Alpha Capital Management Ltd. | 169,746 | $10,468,000 | 1.55% |
| Mesirow Financial Investment Management, Inc. | 5,723 | $353,000 | 1.49% |
| 1492 Capital Management LLC | 25,093 | $1,547,000 | 1.37% |
| THB ASSET MANAGEMENT | 91,018 | $5,613,000 | 1.04% |
| Regent Investment Management LLC | 41,329 | $2,549,000 | 0.78% |
| Phocas Financial Corp. | 101,567 | $6,263,000 | 0.75% |
| INVESTMENT COUNSELORS OF MARYLAND LLC | 284,334 | $17,535,000 | 0.75% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 35,500 | $2,189,000 | 0.70% |